Systemic Deregulation: EPA Directive Undermines Chemical Safety via Industry-Aligned Risk Assessment Framework
Original framing: ““A Huge Setback”: New EPA Directive Could Weaken Hundreds of Chemical Regulations” — ProPublica
Marginalized communities, particularly Black, Indigenous, and low-income populations, bear the brunt of chemical exposure due to systemic racism in zoning and enforcement. The directive exacerbates this by reducing the EPA’s capacity to monitor hotspots like 'Cancer Alley' in Louisiana or Indigenous lands in Alberta’s tar sands. Grassroots groups like the Environmental Justice Health Alliance have documented how deregulation deepens health disparities, yet their expertise is excluded from policy debates.
The EPA’s directive is not an isolated policy failure but a symptom of a 50-year erosion of precautionary principles, driven by industry capture of regulatory science and the marginalization of indigenous and marginalized voices.
Historically, this mirrors the 1980s 'regulatory reform' era, where cost-benefit analyses replaced health protections, benefiting chemical manufacturers like Dow and Monsanto while disproportionately harming Black and Indigenous communities. Cross-culturally, the directive clashes with frameworks like Māori 'kaitiakitanga' or Ubuntu, which treat environmental harm as a moral and communal crisis rather than a technical oversight. Scientifically, the shift toward 'cumulative risk assessment' ignores epigenetic research and synergistic effects, risking generational health crises. The solution lies in reinstating health-based standards, centering indigenous expertise, and enforcing global chemical justice—policies that would require dismantling the epistemic and institutional structures that currently serve corporate power over public health.